Argentus Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Argentus Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,090	Closed	-$274K	–	36
2016 Q3	$274K	Sell	5,090 -685	-12%	-$44K	0.1%	268
2016 Q2	$425K	Sell	5,775 -188	-3%	-$13.3K	0.18%	152
2016 Q1	$381K	Buy	5,963 +3,502	+142%	+$221K	0.13%	194
2015 Q4	$169K	Sell	2,461 -2,164	-47%	-$143K	0.05%	298
2015 Q3	$274K	Buy	+4,625	New	+$293K	0.04%	347
2014 Q1	–	Sell	-10,760	Closed	-$572K	–	195
2013 Q4	$572K	Sell	10,760 -1,824	-14%	-$92.9K	0.12%	132
2013 Q3	$582K	Buy	+12,584	New	+$552K	0.13%	125

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Argentus Capital Management's BMY Position: Q4 2016 in Review

Argentus Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2016, closing a stake of 5,090 shares — an estimated $274K sold.

Argentus Capital Management first reported a position in BMY in Q3 2013 and held it in 7 quarters. The position peaked at $582K in Q3 2013. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

Argentus Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2016 after selling out during the quarter.
Argentus Capital Management sold 5,090 Bristol-Myers Squibb shares in Q4 2016, an estimated $274K.
Argentus Capital Management first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 7 quarters.
Argentus Capital Management's Bristol-Myers Squibb position peaked at $582K in Q3 2013.
1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on Argentus Capital Management's 13F filing for Q4 2016.